Literature DB >> 14727255

Cleavage of von Willebrand factor by ADAMTS-13 on endothelial cells.

José A López1, Jing-fei Dong.   

Abstract

When histamine-stimulated endothelial cells are perfused with platelets in buffer, the platelets form long beads-on-a-string structures on the surface of the cells. The strands connecting the platelets are composed of ultralarge multimers of von Willebrand factor (ULVWF) and can be rapidly cleaved when perfused with normal plasma or purified ADAMTS-13 metalloprotease, but not with plasma from patients with either congenital or acquired thrombotic thrombocytopenic purpura (TTP). These ULVWF strings anchor to the surface of the endothelial cell at least partly through P-selectin, as their formation is prevented by either soluble P-selectin or P-selectin antibodies. They are also able to support the attachment of beads coated with ADAMTS-13. The metalloprotease binds to both the A1 and A3 domains of VWF, the latter with higher affinity. This attachment docks the enzyme close to its substrate site within the A2 domain. We propose that attachment of newly released ULVWF to the endothelial cell surface facilitates its cleavage by ADAMTS-13 by allowing tensile force to be applied to the A2 domain, thereby exposing the ADAMTS-13 cleavage site.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14727255     DOI: 10.1053/j.seminhematol.2003.10.004

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  16 in total

1.  The application of vWF/ADAMTS13 in essential hypertension.

Authors:  Wei-Hong Ma; Lin Sheng; Hui-Ping Gong; Lin-Lin Guo; Qing-Hua Lu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  A factor VIII-derived peptide enables von Willebrand factor (VWF)-binding of artificial platelet nanoconstructs without interfering with VWF-adhesion of natural platelets.

Authors:  Hassan Haji-Valizadeh; Christa L Modery-Pawlowski; Anirban Sen Gupta
Journal:  Nanoscale       Date:  2014-05-07       Impact factor: 7.790

3.  Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13.

Authors:  Arnaud Bonnefoy; Kim Daenens; Hendrik B Feys; Rita De Vos; Petra Vandervoort; Jos Vermylen; Jack Lawler; Marc F Hoylaerts
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

4.  Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions.

Authors:  Zhenyin Tao; Yuandong Peng; Leticia Nolasco; Santiago Cal; Carlos Lopez-Otin; Renhao Li; Joel L Moake; José A López; Jing-Fei Dong
Journal:  Blood       Date:  2005-09-01       Impact factor: 22.113

5.  Shear stress-induced unfolding of VWF accelerates oxidation of key methionine residues in the A1A2A3 region.

Authors:  Xiaoyun Fu; Junmei Chen; Ryan Gallagher; Ying Zheng; Dominic W Chung; José A López
Journal:  Blood       Date:  2011-09-13       Impact factor: 22.113

Review 6.  Endothelial cells and thrombotic microangiopathy.

Authors:  David Motto
Journal:  Semin Nephrol       Date:  2012-03       Impact factor: 5.299

Review 7.  The role of von Willebrand factor in thrombotic microangiopathy.

Authors:  Damien G Noone; Magdalena Riedl; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2017-07-26       Impact factor: 3.714

8.  Platelet recruitment to venous stent thrombi.

Authors:  Robert D McBane; Krzysztof Karnicki; Waldemar E Wysokinski
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

9.  Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in vivo.

Authors:  Junliang Pan; Thanh Theresa Dinh; Anusha Rajaraman; Mike Lee; Alexander Scholz; Cathrin J Czupalla; Helena Kiefel; Li Zhu; Lijun Xia; John Morser; Haiyan Jiang; Laura Santambrogio; Eugene C Butcher
Journal:  Blood       Date:  2016-05-12       Impact factor: 22.113

10.  Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy.

Authors:  Ramesh Tati; Ann-Charlotte Kristoffersson; Anne-Lie Ståhl; Johan Rebetz; Li Wang; Christoph Licht; David Motto; Diana Karpman
Journal:  J Immunol       Date:  2013-07-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.